Prospective evaluation of the management of moderate to severe XXXX with parenteral antibiotics at a paediatric day treatment centre.

@entity1 @entity2756 @entity9856 @entity39 @entity341 @entity2688 @entity794 @entity3402
AIM: To assess the clinical outcome of @entity1 with moderate to severe @entity2688 managed at a paediatric day treatment centre (DTC). METHODS: Prospective observational study of all @entity1 (3 months to 18 years) with a presumed diagnosis of moderate to severe @entity2688 made in a university-affiliated paediatric @entity341 ( @entity341 ) (September 2003 to September 2005). @entity1 treated at the DTC were given @entity2756 or @entity3402 . RESULTS: During the study period, a presumed diagnosis of moderate to severe @entity2688 was made in 224 @entity1 in the @entity341 . Ninety-two @entity1 were treated at the DTC (41%). The @entity2688 had a median width of 7.0 cm (range: 1.0-50.0 cm) and a median length of 6.5 cm (range: 1.0-40.0 cm). Blood cultures were performed in 95.7%; one was positive for @entity794 . After a mean of 2.5 days of intravenous therapy (first injection in the @entity341 and a mean of 1.5 days at the DTC), 73 @entity1 (79.3%) were successfully discharged from the @entity9856 and switched to an oral agent. For these @entity1 no relapse occurred. Nineteen @entity1 (20.7%) required inpatient admission for further therapy. No @entity1 was diagnosed with @entity39 in the course of therapy. Seventy-eight satisfaction questionnaires were handed in and revealed very good to excellent parental satisfaction with treatment at the DTC in 94.8%. CONCLUSION: Treatment with parenteral antibiotic at a DTC is a viable alternative to hospitalisation for moderate to severe @entity2688 in @entity1 .
